AKT1 and breast carcinoma: Exposure of the trastuzumab resistant breast cancer cell lines to 80 and 160 μg/mL EGCG for 72 h led to decrease in cell growth and apoptosis at high concentrations associated with decreased Akt activity and induction of Forkhead box O3 transcription factor protein (FOXO3) [123].